|
1
|
Bonner JA, Harari PM, Giralt J, Azarnia N,
Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, et al:
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head
and neck. N Engl J Med. 354:567–578. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vermorken JB, Mesia R, Rivera F, Remenar
E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol
D, et al: Platinum-based chemotherapy plus cetuximab in head and
neck cancer. N Engl J Med. 359:1116–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rivera F, García-Castaño A, Vega N,
Vega-Villegas ME and Gutiérrez-Sanz L: Cetuximab in metastatic or
recurrent head and neck cancer: The EXTREME trial. Expert Rev
Anticancer Ther. 9:1421–1428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yoshino T, Hasegawa Y, Takahashi S, Monden
N, Homma A, Okami K, Onozawa Y, Fujii M, Taguchi T, de Blas B, et
al: Platinum-based chemotherapy plus cetuximab for the first-line
treatment of Japanese patients with recurrent and/or metastatic
squamous cell carcinoma of the head and neck: Results of a phase II
trial. Jpn J Clin Oncol. 43:524–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kobayashi H, Tanisaka K, Doi O, Kodama K,
Higashiyama M, Nakagawa H, Miyake M, Taki T, Hara S, Yasutomi M, et
al: An in vitro chemosensitivity test for solid human tumors
using collagen gel droplet embedded cultures. Int J Oncol.
11:449–455. 1997.PubMed/NCBI
|
|
6
|
Kobayashi H: Development of a new in vitro
chemosensitivity test using collagen gel droplet embedded culture
and image analysis for clinical usefulness. Recent Results Cancer
Res. 161:48–61. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shintani S, Hino S, Nakashiro K and
Hamakawa H: Clinical trial of chemotherapy identified according to
chemosensitivity assay for oral cancer patients with unresectable
recurrent lesions. Gan To Kagaku Ryoho. 33:357–360. 2006.(In
Japanese). PubMed/NCBI
|
|
8
|
Kobayashi H, Tanisaka K, Kondo N, Mito Y,
Koezuka M, Yokouchi H, Higashiyama M, Kodama K, Doi O and Yamada M:
Development of new in vitro chemosensitivity test using collagen
gel droplet embedded culture and its clinical usefulness. Gan To
Kagaku Ryoho. 22:1933–1939. 1995.(In Japanese). PubMed/NCBI
|
|
9
|
Sakuma K, Tanaka A and Mataga I: Collagen
gel droplet- embedded culture drug sensitivity testing in squamous
cell carcinoma cell lines derived from human oral cancers: Optimal
contact concentrations of cisplatin and fluorouracil. Oncol Lett.
12:4643–4650. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ryuki T, Sakuma K and Tanaka A: Optimal
cetuximab contact concentration using a collagen gel
droplet-embedded culture drug chemosensitivity test in human oral
squamous carcinoma cell lines. Chemotherapy. 7:253–260. 2018.
|
|
11
|
Kiyota N, Tahara M, Kadowaki S, Fuse N,
Doi T, Minami H and Ohtsu A: Systemic chemotherapy with cisplatin
plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma
of the head and neck (R/M SCCHN): Efficacy and safety of a lower
dose of PF (80/800) at a single institution in Japan. Jpn J Clin
Oncol. 39:225–230. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saijo N: Molecular target therapy in
cancer. Nihon Rinsho. 68:1779–1786. 2010.(In Japanese). PubMed/NCBI
|
|
13
|
Saijo N: Molecular targeted therapy for
lung cancer, recent topics. J Lung Cancer. 7:1–8. 2008. View Article : Google Scholar
|
|
14
|
Lurje G and Lenz HJ: EGFR signaling and
drug discovery. Oncology. 77:400–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang SM, Bock JM and Harari PM: Epidermal
growth factor receptor blockade with C225 modulates proliferation,
apoptosis, and radiosensitivity in squamous cell carcinomas of the
head and neck. Cancer Res. 59:1935–1940. 1999.PubMed/NCBI
|
|
16
|
Araki Y, Isomoto H, Matsumoto A, Kaibara
A, Yasunaga M, Hayashi K, Yatsugi H and Yamauchi K: An in vitro
chemosensitivity test for colorectal cancer using collagen-gel
droplet embedded cultures. Kurume Med J. 46:163–166. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawamura M, Inoue Y, Oyama T and Kobayashi
H: Chemosensitivity test for unresectable non-small cell lung
cancer. Nihon Geka Gakkai Zasshi. 103:229–232. 2002.(In Japanese).
PubMed/NCBI
|
|
18
|
Takamura Y, Kobayashi H, Taguchi T,
Motomura K, Inaji H and Noguchi S: Prediction of chemotherapeutic
response by collagen gel droplet embedded culture-drug sensitivity
test in human breast cancers. Int J Cancer. 98:450–455. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sakuma K, Tamura R, Hanyu S, Takahashi H,
Sato H, Oneyama T, Yamaguchi A and Tanaka A: Clinical study on
collagen gel droplet-embedded culture drug sensitivity test for
multidrug combination chemotherapy and super selective
intraarterial infusion chemoradiotherapy in oral squamous cell
carcinoma. Mol Clin Oncol. 7:1021–1026. 2017.PubMed/NCBI
|
|
20
|
Sakuma K, Tamura R, Noda N, Mizutani M,
Yamaguchi A and Tanaka A: Collagen gel droplet-embedded culture
drug sensitivity testing in hard palate cancer-predicted antitumor
efficacy of cetuximab: A case report. Mol Clin Oncol. 7:637–641.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kimura H, Sakai K, Arao T, Shimoyama T,
Tamura T and Nishio K: Antibody-dependent cellular cytotoxicity of
cetuximab against tumor cells with wild-type or mutant epidermal
growth factor receptor. Cancer Sci. 98:1275–1280. 2007. View Article : Google Scholar : PubMed/NCBI
|
